Kanawha Capital Management LLC Abbott Laboratories Transaction History

Kanawha Capital Management LLC

  • $1.29 Billion
  • Q3 2024

A detailed history of Kanawha Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kanawha Capital Management LLC holds 177,530 shares of ABT stock, worth $20.3 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
177,530
Previous 186,172 4.64%
Holding current value
$20.3 Million
Previous $19.3 Million 4.63%
% of portfolio
1.56%
Previous 1.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$100.07 - $118.13 $864,804 - $1.02 Million
-8,642 Reduced 4.64%
177,530 $20.2 Million
Q2 2024

Jul 25, 2024
BUY
$100.73 - $112.44 $840,289 - $937,974
8,342 Added 4.69%
186,172 $19.3 Million
Q1 2024

Apr 29, 2024
BUY
$109.52 - $120.96 $344,002 - $379,935
3,141 Added 1.8%
177,830 $20.2 Million
Q4 2023

Jan 29, 2024
SELL
$90.19 - $110.4 $730,088 - $893,688
-8,095 Reduced 4.43%
174,689 $19.2 Million
Q3 2023

Oct 26, 2023
BUY
$95.53 - $114.62 $52,254 - $62,697
547 Added 0.3%
182,784 $17.7 Million
Q2 2023

Jul 28, 2023
BUY
$100.78 - $112.29 $56,839 - $63,331
564 Added 0.31%
182,237 $19.9 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $292,226 - $343,968
3,017 Added 1.69%
181,673 $18.4 Million
Q4 2022

Feb 01, 2023
BUY
$95.06 - $111.52 $129,091 - $151,444
1,358 Added 0.77%
178,656 $19.6 Million
Q3 2022

Oct 31, 2022
SELL
$96.76 - $112.03 $72,666 - $84,134
-751 Reduced 0.42%
177,298 $17.2 Million
Q2 2022

Jul 27, 2022
BUY
$102.07 - $123.37 $37,051 - $44,783
363 Added 0.2%
178,049 $19.3 Million
Q1 2022

Apr 26, 2022
BUY
$114.02 - $139.04 $306,941 - $374,295
2,692 Added 1.54%
177,686 $21 Million
Q4 2021

Jan 31, 2022
SELL
$115.53 - $141.46 $310,082 - $379,678
-2,684 Reduced 1.51%
174,994 $24.6 Million
Q3 2021

Oct 28, 2021
SELL
$116.66 - $129.06 $398,627 - $440,998
-3,417 Reduced 1.89%
177,678 $21 Million
Q2 2021

Jul 22, 2021
BUY
$105.79 - $124.53 $134,670 - $158,526
1,273 Added 0.71%
181,095 $21 Million
Q1 2021

Apr 26, 2021
SELL
$108.84 - $128.23 $352,315 - $415,080
-3,237 Reduced 1.77%
179,822 $21.6 Million
Q4 2020

Feb 01, 2021
BUY
$105.0 - $114.42 $78,015 - $85,014
743 Added 0.41%
183,059 $20 Million
Q3 2020

Oct 29, 2020
SELL
$91.64 - $111.29 $133,152 - $161,704
-1,453 Reduced 0.79%
182,316 $19.8 Million
Q2 2020

Aug 04, 2020
BUY
$76.57 - $98.0 $66,386 - $84,966
867 Added 0.47%
183,769 $16.8 Million
Q1 2020

May 04, 2020
BUY
$62.82 - $91.86 $84,744 - $123,919
1,349 Added 0.74%
182,902 $14.4 Million
Q4 2019

Jan 31, 2020
BUY
$78.51 - $87.4 $853,796 - $950,475
10,875 Added 6.37%
181,553 $15.8 Million
Q3 2019

Nov 01, 2019
BUY
$81.84 - $88.74 $61,298 - $66,466
749 Added 0.44%
170,678 $14.3 Million
Q2 2019

Jul 30, 2019
BUY
$72.88 - $85.0 $53,931 - $62,900
740 Added 0.44%
169,929 $14.3 Million
Q1 2019

Apr 23, 2019
SELL
$66.22 - $80.06 $103,104 - $124,653
-1,557 Reduced 0.91%
169,189 $13.5 Million
Q4 2018

Jan 23, 2019
BUY
$65.56 - $74.27 $36,975 - $41,888
564 Added 0.33%
170,746 $12.4 Million
Q3 2018

Oct 25, 2018
BUY
$60.81 - $73.36 $32,350 - $39,027
532 Added 0.31%
170,182 $12.5 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $19,573 - $21,603
-340 Reduced 0.2%
169,650 $10.3 Million
Q1 2018

Apr 19, 2018
SELL
$56.27 - $63.62 $44,959 - $50,832
-799 Reduced 0.47%
169,990 $10.2 Million
Q4 2017

Jan 26, 2018
BUY
$53.68 - $57.47 $6,119 - $6,551
114 Added 0.07%
170,789 $9.75 Million
Q3 2017

Oct 26, 2017
BUY
$48.06 - $53.64 $8.2 Million - $9.16 Million
170,675
170,675 $9.11 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Kanawha Capital Management LLC Portfolio

Follow Kanawha Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kanawha Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kanawha Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email